兽医骨科植入物市场机会、成长动力、产业趋势分析及 2025-2034 年预测

2024 年全球兽医骨科植入物市场价值为 6.17 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 7.7%。动物骨科疾病和肌肉骨骼损伤盛行率的上升是推动市场成长的关键因素。随着越来越多的宠物和牲畜出现行动不便的问题，对先进手术解决方案的需求持续激增。兽医专业人员越来越多地采用骨科植入物来改善治疗效果，而植入物材料和设计的技术进步也提高了手术的精确度。

宠物主人越来越关注宠物的健康，这推动了对专门骨科手术的需求。随着诊断能力的提高，人们对治疗方案的认识不断提高，导致兽医植入物的采用率更高。接受过骨科手术培训的兽医数量的增加以及拥有先进手术能力的兽医诊所的扩张正在进一步加速市场扩张。此外，涵盖骨科手术的宠物保险政策的增加鼓励宠物主人选择手术，进一步推动了兽医骨科植入物的采用。

植入物领域占据了市场主导地位，2024 年市场规模达到 4.01 亿美元，这主要是由于对患有骨科损伤的动物进行手术干预的需求不断增长。兽医专业人员越来越依赖钢板、骨螺钉、关节植入物和其他手术器械来治疗骨折、韧带撕裂和关节疾病。针对这些情况的治疗程序不断增加，推动了对先进植入物设计的需求，这些设计可以提供更高的精度、缩短恢復时间并增强接受治疗的动物的活动能力。微创手术技术越来越受到人们的关注，因为它们为治疗肌肉骨骼疾病提供了更有效的解决方案，并减少了术后併发症。

受宠物收养量大幅增加的推动，伴侣动物在 2024 年占据兽医骨科植入物市场 72.5% 的主导份额。随着全球越来越多的家庭饲养宠物，尤其是狗和猫，兽医护理的支出也随之增加。宠物主人在骨科治疗方面投入更多资金，以改善宠物的生活质量，从而导致对专用植入物的需求增加。宠物人性化的趋势——主人将动物视为家庭成员——进一步促进了市场扩张。

北美引领全球市场，2024 年占 45.2% 的份额，这得益于高宠物拥有率和先进的兽医医疗保健基础设施。该地区拥有大量配备最先进手术技术的专业兽医诊所和医院，推动了对骨科植入物的需求。兽医骨科领域正在进行的研究和开发工作正在推动创新，使治疗程序更加有效和便利。随着植入技术的不断进步和宠物护理支出的增加，北美仍然是兽医骨科植入物市场的主导力量。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 狗狗骨科疾病发生率不断上升
    • 兽医骨科技术的进步
    • 扩大宠物保险覆盖范围
  • 产业陷阱与挑战
    • 骨科手术和植入物费用高昂
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 植入物
  • 盘子
    • TPLO板
    • TTA板
    • 特种板材
    • 创伤板
    • 其他板块
  • 关节植入物
  • 骨螺丝和锚
  • 针脚和电线
  • 其他植入物
• 仪器

第六章：市场估计与预测：依动物类型，2021 年至 2034 年

• 主要趋势
• 伴侣动物
  • 狗
  • 猫
  • 其他伴侣动物
• 家畜

第七章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 胫骨平台平整截骨术（TPLO）
• 胫骨结节推进术（TTA）
• 关节置换
  • 髋关节置换术
  • 膝关节置换术
  • 手肘关节置换术
  • 踝关节置换术
• 创伤
• 其他应用

第八章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 兽医医院和诊所
• 其他最终用途

第九章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• AmerisourceBergen Corporation
• Arthrex Vet Systems
• B. Braun SE
• BlueSAO
• BioMedtrix
• DePuy Synthes (Johnson & Johnson)
• Fusion Implants
• Integra LifeSciences
• Kyon
• Movora (Vimian Group AB)
• Narang Medical Limited
• Orthomed
• Ortho Max
• Veterinary Instrumentation
• STERIS

The Global Veterinary Orthopedic Implants Market was valued at USD 617 million in 2024 and is projected to expand at a CAGR of 7.7% from 2025 to 2034. The rising prevalence of orthopedic disorders and musculoskeletal injuries in animals is a key factor driving market growth. As more pets and livestock develop mobility-related issues, the demand for advanced surgical solutions continues to surge. Veterinary professionals are increasingly adopting orthopedic implants to improve treatment outcomes, while technological advancements in implant materials and design are enhancing surgical precision.

Pet owners are becoming more proactive about their animal's health, fueling demand for specialized orthopedic procedures. The growing awareness of treatment options, in line with improved diagnostic capabilities, is leading to higher adoption rates for veterinary implants. The increasing number of veterinarians trained in orthopedic procedures and the expansion of veterinary clinics with advanced surgical capabilities are further accelerating market expansion. Additionally, the rise in pet insurance policies covering orthopedic procedures is encouraging pet owners to opt for surgeries, further propelling the adoption of veterinary orthopedic implants.

The implants segment dominated the market, generating USD 401 million in 2024, primarily due to the growing need for surgical interventions in animals with orthopedic injuries. Veterinary professionals are relying more on plates, bone screws, joint implants, and other surgical devices to treat fractures, ligament tears, and joint disorders. The rising number of procedures addressing these conditions is pushing demand for advanced implant designs that offer greater precision, reduce recovery time, and enhance mobility in treated animals. Minimally invasive surgical techniques are gaining traction as they provide more efficient solutions for treating musculoskeletal conditions with reduced post-operative complications.

Companion animals accounted for a dominant 72.5% share of the veterinary orthopedic implants market in 2024, driven by a significant surge in pet adoption. With more households worldwide owning pets, particularly dogs and cats, spending on veterinary care has increased. Pet owners are investing more in orthopedic treatments to improve their pets' quality of life, leading to higher demand for specialized implants. The trend of humanizing pets-where owners view animals as family members-is further contributing to market expansion.

North America led the global market, holding a 45.2% share in 2024, supported by high pet ownership rates and an advanced veterinary healthcare infrastructure. The region's strong presence of specialized veterinary clinics and hospitals equipped with state-of-the-art surgical technologies has boosted demand for orthopedic implants. Ongoing research and development efforts in veterinary orthopedics are driving innovation, making procedures more effective and accessible. With continued advancements in implant technology and increasing pet care expenditure, North America remains a dominant force in the veterinary orthopedic implants market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of orthopedic conditions in dogs
    • 3.2.1.2 Advancements in veterinary orthopedic technology
    • 3.2.1.3 Expansion of pet insurance coverage
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of orthopedic procedures and implants
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Implants
  • 5.2.1 Plates
    • 5.2.1.1 TPLO plates
    • 5.2.1.2 TTA plates
    • 5.2.1.3 Specialty plates
    • 5.2.1.4 Trauma plates
    • 5.2.1.5 Other plates
  • 5.2.2 Joint implants
  • 5.2.3 Bone screws and anchors
  • 5.2.4 Pins and wires
  • 5.2.5 Other implants
• 5.3 Instruments

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Companion animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Other companion animals
• 6.3 Livestock animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Tibial Plateau Leveling Osteotomy (TPLO)
• 7.3 Tibial Tuberosity Advancement (TTA)
• 7.4 Joint replacement
  • 7.4.1 Hip replacement
  • 7.4.2 Knee replacement
  • 7.4.3 Elbow replacement
  • 7.4.4 Ankle replacement
• 7.5 Trauma
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals and clinics
• 8.3 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 AmerisourceBergen Corporation
• 10.2 Arthrex Vet Systems
• 10.3 B. Braun SE
• 10.4 BlueSAO
• 10.5 BioMedtrix
• 10.6 DePuy Synthes (Johnson & Johnson)
• 10.7 Fusion Implants
• 10.8 Integra LifeSciences
• 10.9 Kyon
• 10.10 Movora (Vimian Group AB)
• 10.11 Narang Medical Limited
• 10.12 Orthomed
• 10.13 Ortho Max
• 10.14 Veterinary Instrumentation
• 10.15 STERIS